Glucose enhancement of performance on memory tests in young and aged humans

Naloxone modulates the behavioral effects of cholinergic agonists and antagonists

Peripheral glucose administration enhances memory in rodents and humans. Recent findings suggest that glucose may affect behavior, in part, by augmenting central cholinergic functions and by attenuating central opiate functions. The present experiments examined interactions between an opiate antagonist, naloxone, and cholinergic agents to determine whether the effects would parallel those found with glucose. Three behavioral measures were assessed: tremors, hyperactivity, and spontaneous alternation. Naloxone (1 mg/kg) significantly augmented tremors elicited by physostigmine (0.3 mg/kg). Naloxone (1 mg/kg) also attenuated increases in locomotor activity and impairments in spontaneous alternation performance elicited by scopolamine (1 and 3 mg/kg for activity and alternation measures, respectively). Thus, across three diverse measures, naloxone produced effects similar to those previously reported for glucose. These findings are consistent with the hypothesis that release of cholinergic activity from opiate inhibition may contribute to glucose effects on behavior.

Effects of glucose on memory processes in young adults

Recent studies suggest that glucose enhances memory in rodents and humans. The present experiment investigated the effects of glucose on memory performance and blood glucose changes in young adults (19-25 years). Subjects ingested (300 ml beverage) three doses of glucose (0, 30, 100 g) in a random, double-blind, triple crossover design. Thirty minutes post-glucose, subjects were shown nouns on a computer monitor and then administered recall and recognition memory tests. Blood samples were drawn at regular intervals. There was no effect of glucose on memory performance, and plasma glucose measures did not correlate with memory test scores. Statistical power was adequate to detect a medium effect. The results contradict the hypothesis that glucose enhances memory performance in young, healthy normal adults.

Glucose and physostigmine effects on morphine- and amphetamine-induced increases in locomotor activity in mice

Recent findings indicate that glucose antagonizes several behavioral effects of cholinergic antagonists and augments those of cholinergic agonists. For example, scopolamine elicits increased locomotor activity, an action which is attenuated by glucose and by combined treatment with glucose and physostigmine at doses which are individually without effect. Opiate and catecholamine agonists, such as morphine and amphetamine, also elicit hyperactivity. The present study examined interactions of glucose and physostigmine with morphine- and amphetamine-induced hyperactivity. Mice received saline, morphine (10 mg/kg), or amphetamine (1 mg/kg) 50 min prior to testing, followed by saline, physostigmine (0.01, 0.05, 0.1, or 0.2 mg/kg), or glucose (10, 50, 100, or 500 mg/kg) administered 20 min prior to activity testing in an open field. Physostigmine significantly attenuated both morphine- and amphetamine-induced increases in activity, but higher doses were required to attenuate the effects of amphetamine. Like physostigmine, glucose significantly attenuated morphine-induced activity levels, but unlike physostigmine, glucose did not attenuate amphetamine-induced activity. Thus, the behavioral effects of morphine were more susceptible to modification by physostigmine and glucose than were the effects of amphetamine. The attenuation of morphine-induced hyperactivity demonstrates a similarity between glucose and cholinergic agonists, and also indicates that glucose may inhibit, directly or indirectly, opiate functions. More generally, these findings add to the evidence that circulating glucose levels selectively influence a growing list of behavioral and neurobiological functions.

Adrenalectomy-induced memory deficits: role of plasma glucose levels

Circulating glucose levels regulate memory storage under several conditions. This study examined the contribution of blood glucose levels to the transient memory impairment seen in adrenalectomized rats. Inhibitory (passive) avoidance retention performance, blood glucose levels, and glycemic responses to footshock were tested 1, 2, and 8 days after adrenalectomy. Adrenalectomized animals demonstrated a transient inhibitory avoidance deficit 1 and 2 days after surgery which recovered by 8 days. The adrenalectomy-induced memory deficit was accompanied by decreased resting blood glucose levels. In animals tested 2 days after adrenalectomy, this decrease in baseline blood glucose levels was exacerbated by further reductions, rather than the normal increases, in circulating glucose levels after training. The magnitude of blood glucose increases after glucose injection was decreased in adrenalectomized animals tested 2 days after surgery. Posttraining glucose injections restored the retention performance of animals trained 2 days after adrenalectomy to that of sham-operated animals. These findings suggest that abnormalities in blood glucose regulation may contribute, in part, to the transient memory impairment seen after adrenalectomy. Additionally, the results further implicate blood glucose in the regulation of CNS information processing systems.

An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers

This review presents evidence that some cognition enhancing drugs produce their beneficial effects on learning and memory by increasing the availability of glucose for uptake and utilization into the brain. The hypothesis further suggests that many cognition enhancing drugs act through a peripheral mechanism rather than directly on the brain. The general hypothesis is supported by four independent and converging pieces of evidence: 1) Some cognition enhancing drugs may not cross the blood-brain barrier, but can still facilitate memory; 2) Some cognition enhancing drugs are effective only when injected peripherally, but not when injected directly into the brain; 3) Many cognition enhancing drugs are not effective after adrenalectomy; 4) Cognitive function is correlated with glucose regulation in aged animals and humans. These four lines of research have implications for the role of glucose in the action of specific cognitive enhancers.